List of Tables
Table 1. Urea Cycle Disorders Treatment Drug Market Trends
Table 2. Urea Cycle Disorders Treatment Drug Market Drivers & Opportunity
Table 3. Urea Cycle Disorders Treatment Drug Market Challenges
Table 4. Urea Cycle Disorders Treatment Drug Market Restraints
Table 5. Global Urea Cycle Disorders Treatment Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Urea Cycle Disorders Treatment Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Urea Cycle Disorders Treatment Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Urea Cycle Disorders Treatment Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Urea Cycle Disorders Treatment Drug
Table 10. Global Urea Cycle Disorders Treatment Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urea Cycle Disorders Treatment Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Urea Cycle Disorders Treatment Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Urea Cycle Disorders Treatment Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Urea Cycle Disorders Treatment Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Urea Cycle Disorders Treatment Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Urea Cycle Disorders Treatment Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Urea Cycle Disorders Treatment Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Urea Cycle Disorders Treatment Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Urea Cycle Disorders Treatment Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Urea Cycle Disorders Treatment Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Urea Cycle Disorders Treatment Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Urea Cycle Disorders Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Urea Cycle Disorders Treatment Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Urea Cycle Disorders Treatment Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Urea Cycle Disorders Treatment Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Urea Cycle Disorders Treatment Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Urea Cycle Disorders Treatment Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Urea Cycle Disorders Treatment Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Urea Cycle Disorders Treatment Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Horizon Therapeutics Plc Basic Information List
Table 32. Horizon Therapeutics Plc Description and Business Overview
Table 33. Horizon Therapeutics Plc Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Horizon Therapeutics Plc (2019-2024)
Table 35. Horizon Therapeutics Plc Recent Developments
Table 36. Bausch Health Companies Inc. Basic Information List
Table 37. Bausch Health Companies Inc. Description and Business Overview
Table 38. Bausch Health Companies Inc. Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Bausch Health Companies Inc. (2019-2024)
Table 40. Bausch Health Companies Inc. Recent Developments
Table 41. Recordati Rare Diseases Inc. Basic Information List
Table 42. Recordati Rare Diseases Inc. Description and Business Overview
Table 43. Recordati Rare Diseases Inc. Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Recordati Rare Diseases Inc. (2019-2024)
Table 45. Recordati Rare Diseases Inc. Recent Developments
Table 46. Nestle S.A. Basic Information List
Table 47. Nestle S.A. Description and Business Overview
Table 48. Nestle S.A. Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Nestle S.A. (2019-2024)
Table 50. Nestle S.A. Recent Developments
Table 51. Danone S.A. Basic Information List
Table 52. Danone S.A. Description and Business Overview
Table 53. Danone S.A. Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Danone S.A. (2019-2024)
Table 55. Danone S.A. Recent Developments
Table 56. Lucane Pharma SA Basic Information List
Table 57. Lucane Pharma SA Description and Business Overview
Table 58. Lucane Pharma SA Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Lucane Pharma SA (2019-2024)
Table 60. Lucane Pharma SA Recent Developments
Table 61. Acer Therapeutics Inc. Basic Information List
Table 62. Acer Therapeutics Inc. Description and Business Overview
Table 63. Acer Therapeutics Inc. Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Acer Therapeutics Inc. (2019-2024)
Table 65. Acer Therapeutics Inc. Recent Developments
Table 66. Ultragenyx Pharmaceutical Basic Information List
Table 67. Ultragenyx Pharmaceutical Description and Business Overview
Table 68. Ultragenyx Pharmaceutical Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Ultragenyx Pharmaceutical (2019-2024)
Table 70. Ultragenyx Pharmaceutical Recent Developments
Table 71. Aeglea Biotherapeutics, Inc Basic Information List
Table 72. Aeglea Biotherapeutics, Inc Description and Business Overview
Table 73. Aeglea Biotherapeutics, Inc Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Aeglea Biotherapeutics, Inc (2019-2024)
Table 75. Aeglea Biotherapeutics, Inc Recent Developments
Table 76. Arcturus Therapeutics Holdings Inc. Basic Information List
Table 77. Arcturus Therapeutics Holdings Inc. Description and Business Overview
Table 78. Arcturus Therapeutics Holdings Inc. Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Arcturus Therapeutics Holdings Inc. (2019-2024)
Table 80. Arcturus Therapeutics Holdings Inc. Recent Developments
Table 81. Orpharma Pty Ltd. Basic Information List
Table 82. Orpharma Pty Ltd. Description and Business Overview
Table 83. Orpharma Pty Ltd. Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Orpharma Pty Ltd. (2019-2024)
Table 85. Orpharma Pty Ltd. Recent Developments
Table 86. Selecta Biosciences, Inc. Basic Information List
Table 87. Selecta Biosciences, Inc. Description and Business Overview
Table 88. Selecta Biosciences, Inc. Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Selecta Biosciences, Inc. (2019-2024)
Table 90. Selecta Biosciences, Inc. Recent Developments
Table 91. Abbott Basic Information List
Table 92. Abbott Description and Business Overview
Table 93. Abbott Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Abbott (2019-2024)
Table 95. Abbott Recent Developments
Table 96. Mead Johnson & Company, LLC Basic Information List
Table 97. Mead Johnson & Company, LLC Description and Business Overview
Table 98. Mead Johnson & Company, LLC Urea Cycle Disorders Treatment Drug Products, Services and Solutions
Table 99. Revenue (US$ Million) in Urea Cycle Disorders Treatment Drug Business of Mead Johnson & Company, LLC (2019-2024)
Table 100. Mead Johnson & Company, LLC Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Urea Cycle Disorders Treatment Drug Downstream Customers
Table 104. Urea Cycle Disorders Treatment Drug Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Urea Cycle Disorders Treatment Drug Product Picture
Figure 2. Global Urea Cycle Disorders Treatment Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Urea Cycle Disorders Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Urea Cycle Disorders Treatment Drug Report Years Considered
Figure 5. Global Urea Cycle Disorders Treatment Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Urea Cycle Disorders Treatment Drug Revenue in 2023
Figure 7. Urea Cycle Disorders Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Amino Acid Supplements Picture
Figure 9. Sodium Phenylbutyrate Picture
Figure 10. Glycerol Phenylbutyrate Picture
Figure 11. Sodium Benzoate Picture
Figure 12. Others Picture
Figure 13. Global Urea Cycle Disorders Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Urea Cycle Disorders Treatment Drug Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Clinic
Figure 17. Product Picture of Others
Figure 18. Global Urea Cycle Disorders Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Urea Cycle Disorders Treatment Drug Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Urea Cycle Disorders Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Urea Cycle Disorders Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Urea Cycle Disorders Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Urea Cycle Disorders Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Urea Cycle Disorders Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Urea Cycle Disorders Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Urea Cycle Disorders Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Urea Cycle Disorders Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Urea Cycle Disorders Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Urea Cycle Disorders Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Urea Cycle Disorders Treatment Drug Sales Value (%), (2019-2030)
Figure 31. United States Urea Cycle Disorders Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Urea Cycle Disorders Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Urea Cycle Disorders Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Urea Cycle Disorders Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Urea Cycle Disorders Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Urea Cycle Disorders Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 37. China Urea Cycle Disorders Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Urea Cycle Disorders Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 39. China Urea Cycle Disorders Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Urea Cycle Disorders Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Urea Cycle Disorders Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Urea Cycle Disorders Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Urea Cycle Disorders Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Urea Cycle Disorders Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Urea Cycle Disorders Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Urea Cycle Disorders Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Urea Cycle Disorders Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Urea Cycle Disorders Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. India Urea Cycle Disorders Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Urea Cycle Disorders Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 51. India Urea Cycle Disorders Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 52. Urea Cycle Disorders Treatment Drug Industrial Chain
Figure 53. Urea Cycle Disorders Treatment Drug Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
